Absent myocardial I-123 BMIPP uptake in a family
- 23 Downloads
A 72-year-old woman with hypertension showed no sign of myocardial accumulation of123I-BMIPP, and201Tl and123I-MIBG scintigraphy demonstrated normal findings. Electrocardiography showed left axis deviation with inverted T waves in leads I, aVL, V2–6 and QT prolongation. Coronary arteriography, two dimensional echo cardiography and laboratory data showed no abnormality. Her 66-year-old sister with non-insulin-dependent diabetes mellitus also had no myocardial BMIPP uptake, but had normal201Tl finding. ECG and chest film findings were normal. Laboratory data indicated slightly high fasted blood glucose, triglyceride and total cholesterol. Four sons of a 72-year-old woman also underwent BMIPP scintigraphy. No BMIPP uptake was also observed in her 2nd son (49 years old) and his electrocardiogram showed QT prolongation. Since these rare findings indicating no myocardial BMIPP uptake were seen in a family, we suspected that a hereditary myocardial metabolic abnormality accounted for them.
Key wordsI-123 BMIPP hereditary abnormality myocardial fatty acid metabolism
Unable to display preview. Download preview PDF.
- 2.Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid.J Nucl Med 33: 659–667, 1992.PubMedGoogle Scholar
- 10.Taki J, Nakajima K, Matsunari I, Bunko H, Takada S, Tonami N. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.Eur J Nucl Med 22: 1385–1392, 1995.PubMedCrossRefGoogle Scholar
- 12.Torizuka K, Yonekura Y, Nishimura T, Tamaki N, Uehara T. Phase 2 study of beta-methyl-p-(123I)-iodophenylpentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism.KAKU IGAKU (Jpn J Nucl Med) 29: 305–317, 1992.Google Scholar
- 13.Torizuka K, Yonekura Y, Nishimura T, Ohtake T, Bunko H, Tamaki N, et al. Phase 3 study of beta-methyl-p-(123I)iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism—a multi-center trial.KAKU IGAKU (Jpn J Nucl Med) 29: 413–433, 1992.Google Scholar
- 14.Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP), in relation to ATP content.J Nucl Med 31: 1818–1822, 1990.PubMedGoogle Scholar
- 15.Fujibayashi Y, Yonekura Y, Kawai C, Yamamoto K, Tamaki N, Konishi J, et al. Basic studies on I-123-beta-methyl-piodophenyl-pentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxydation inhibitor.KAKU IGAKU (Jpn J Nucl Med) 25: 1131–1135, 1988.Google Scholar
- 16.Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Magata Y, Torizuka T, et al. Assessment of fatty acid metabolism using I-123 branched fatty acid: Comparison with positron emission tomography.Ann Nucl Med 7: SII-41–SII-47, 1993.Google Scholar
- 19.Sorrentino D, Stump D, Potter DJ, Robinson RB, White R, Kiang CL, et al. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut.J Clin Invest 82: 928–935, 1988.PubMedCrossRefGoogle Scholar